RVL Pharmaceuticals plc

NASDAQ:RVLP   1:25:54 PM EDT
1.50
+0.11 (+7.91%)
Other Pre-Announcement

RVL Pharmaceuticals PLC Reports First Quarter 2022 Financial Results Provides Commercial Update

Published: 05/12/2022 11:05 GMT
RVL Pharmaceuticals plc (RVLP) - Reports First Quarter 2022 Financial Results; Provides Commercial Update.
Q1 Revenue $21.4 Million.
Qtrly Loss per Share $0.08.company Reaffirms Its Guidance Targeting Net Sales of Upneeq for Q4 of 2022 of $20.0 to 25.0 Million.
Q1 Earnings per Share View $-0.21, Revenue View $7.4 Million -- Refinitiv Ibes Data (analyst estimates).